PAREXEL International Corp (NASDAQ:PRXL)

CAPS Rating: 5 out of 5

The Company provides a range of expertise in clinical research, medical communications services, consulting, and informatics and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.


Player Avatar BobLangley (80.81) Submitted: 10/20/2008 11:22:03 PM : Outperform Start Price: $21.52 PRXL Score: +39.19

Considerable backlog exists for the services of this clinical research and marketing company whose stock has taken an unjustified hit of late.

Featured Broker Partners